· Anemia of chronic disease; poor renal function from HTN and DM
· Iron studies: serum iron, TIBC, ferritin
· Vitamin B12 is absorbed in the terminal ileum, attached to intrinsic factor; due to gastric bypass surgery the gut absorption has been damaged/reduced, resulting in macrocytic anemia and ineffective erythropoiesis from vitamin B12 deficiency
· Hereditary spherocytosis (HS) is the most common hemolytic anemia due to a red cell membrane defect. It is a result of heterogeneous alterations in one of six genes (most often the ankyrin gene) that encode for proteins involved in vertical associations that tie the membrane skeleton to the lipid bilayer.
· Hemoglobin electrophoresis
· Refer to Hematology for classification of the type of von Willebrand disease and appropriate treatment
· Thalassemia, most likely β-thalssemia minor based on ethnic/racial heritage, minor anemia without symptoms
· Polycythemia vera
· Glucose-6-phosphate dehydrogenase (G6PD) deficiency will cause hemolytic anemia with ingestion of certain foods or medications, including fava beans
· CT angiogram to diagnosis acute pulmonary embolism
· Idiopathic (immune) thrombocytopenic purpura (ITP)
· Factor V is a procoagulant clotting factor that amplifies the production of thrombin, the central enzyme in formation of fibrinogen from fibrin, which leads to clot formation. Factor V Leiden results from a single point mutation in the factor V gene, which leads to a single amino acid change. The factor V Leiden mutation simultaneously increases coagulation by creating two distinct changes in the coagulation cascade: Reduced anticoagulant role of factor V and Enhanced procoagulant role of factor Va. The dual roles of factor V also help to explain why the risk of thrombosis is greater in patients homozygous or pseudohomozygous for factor V Leiden. The plasma of heterozygotes contains factor V Leiden and normal factor V. The normal factor V has APC cofactor activity for the inactivation of factor VIIIa, affording some protection against thrombosis. [from uptodate.com]
· She needs to be evaluated for an inherited thrombophilia, including Factor V Leiden, protein C/S deficiency, prothrombin gene mutation, and antithrombin deficiency (she ended up having protein C deficiency, and with appropriate antepartum treatment now has 3 healthy children)
· Deep venous thrombosis (DVT)
· Low molecular weight heparin (Lovenox) SQ daily and begin warfarin therapy; discontinue Lovenox when INR reaches 2-3, continue warfarin 6-9 mos with goal INR 2-3. Discontinue OCP indefinitely, consider evaluation for inherited thrombophilia.
· Assuming she is no longer on Lovenox (d/c Lovenox immediately if she is still taking it), hold warfarin for 2 days, give an injection of vitamin K today and recheck INR in 2 days. · Please note, this is what I would do; you will find a lot of clinical variability in managing warfarin, and as long as you have close follow up of your patient it will turn out ok!
· Acute myeloid leukemia (AML)
· Chronic myeloid leukemia (CML)
· Excisional biopsy of the lymph node for probably lymphoma
· Chronic lymphocytic leukemia (CLL)